Pelagos Insurance Capital Ltd (PLGO)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Pelagos Insurance Capital Ltd.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 14 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 25.30 $ — 94% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AAQS
8/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 23.1%
- Exp. sales growth 3Y > 5% 15.6%
- EBIT growth 10Y > 5% 17.4%
- Exp. EBIT growth 3Y > 5% 38.6%
- Net debt < 4x EBIT -2.2x
- EBIT positive, 10Y straight 6
- Max. EBIT decline < 50% 93.3%
- Return on equity > 15% 17.2%
- ROCE > 15% 8.3%
- Expected return > 10% 14.3%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
ThreatenedDer Geschäftsbericht 20-F für 2025 widmet künstlicher Intelligenz einen eigenen Risikofaktor: Wettbewerber könnten KI schneller oder erfolgreicher einsetzen, „insurtech“-Anbieter greifen mit Big-Data- und KI-Werkzeugen an, und die EU-KI-Verordnung droht mit Bußgeldern von bis zu 7 Prozent des weltweiten Jahresumsatzes; ein eigenes KI-Produkt oder ein bezifferter KI-Nutzen wird dagegen nirgends genannt.
View the full file — quotes, sources, reviewed filings
„The rapid development of AI and the limited number of established laws, regulations or industry standards specifically governing its use may increase compliance and governance risks. The Group may also face challenges in obtaining and retaining personnel, expertise, intellectual property or other resources needed to develop, implement and maintain AI tools effectively. Competitors or other market participants may adopt AI or generative AI more quickly or more successfully than the Group, which could negatively affect the Group’s competitive position."
Die rasche Entwicklung von KI und die geringe Zahl etablierter Gesetze, Vorschriften oder Branchenstandards, die ihren Einsatz ausdrücklich regeln, können Compliance- und Governance-Risiken erhöhen. Der Konzern könnte zudem Schwierigkeiten haben, Personal, Fachwissen, geistiges Eigentum oder andere Ressourcen zu gewinnen und zu halten, die nötig sind, um KI-Werkzeuge wirksam zu entwickeln, einzuführen und zu pflegen. Wettbewerber oder andere Marktteilnehmer könnten KI oder generative KI schneller oder erfolgreicher einsetzen als der Konzern, was dessen Wettbewerbsposition beeinträchtigen könnte.
„We may also face competition from non-traditional competitors, as well as “insurtech” start-up companies and others who aim to leverage access to “big data,” artificial intelligence or other emerging technologies to gain a competitive advantage."
Wir können auch dem Wettbewerb nicht-traditioneller Anbieter ausgesetzt sein, ebenso „insurtech“-Neugründungen und anderen, die sich über den Zugang zu „Big Data“, künstlicher Intelligenz oder weiteren neuen Technologien einen Wettbewerbsvorteil verschaffen wollen.
„Non-compliance with the AI Act may be subject to regulatory fines of up to 7% of annual worldwide turnover or €35 million."
Verstöße gegen die KI-Verordnung können mit Bußgeldern von bis zu 7 Prozent des weltweiten Jahresumsatzes oder 35 Millionen Euro geahndet werden.
Filings Reviewed: 20-F 2026-03-05 · 6-K 2026-05-13 · 6-K 2026-05-12 · 6-K 2026-05-07 · 6-K 2026-05-07 · 6-K 2026-02-25
Rated on July 27, 2026 · How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 12.7% failed
- More than 10% revenue growth is expected for the coming year 10.3% passed
- Share count grows by less than 3% a year -2.9% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -15.9% failed
- Gross margin at 40% or higher and without meaningful erosion 19.4% failed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 606 m net cash passed
- Operating cash flow covers the profits of the last three years -1,766 m failed
- Return on capital at 15% or higher, or up versus two years ago 8.3% failed
- Insiders hold at least 10% or are net buyers 15.7% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 1.7% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 3.55 | 3.40 – 3.78 | 2,639 | 84.7% | 9 |
| 12/31/2027 | 4.06 | 3.60 – 4.33 | 2,903 | 14.5% | 9 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.88 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -1.09 | -156.70 | 680 | 22.80 | -18.00 | 126 | 125 |
| 2025: Q1 | -0.38 | -155.50 | 578 | 11.10 | -7.40 | -433 | -433 |
| 2025: Q2 | 0.18 | -60.50 | 591 | 9.30 | 3.30 | -359 | -359 |
| 2025: Q3 | 1.24 | 41.70 | 650 | -4.50 | 20.10 | 155 | 155 |
| 2025: Q4 | 1.17 | – | 275 | -59.60 | 42.90 | 229 | 229 |
| 2026: Q1 | 1.15 | – | 612 | 6.00 | 17.60 | 274 | 274 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2020 | 769 | 124 | 127 | 1.09 | 316 | – | – |
| 2021 | 1,177 | 79 | 68 | 0.59 | 368 | 2,014 | 5,325 |
| 2022 | 1,516 | 80 | 53 | 0.45 | 741 | 1,977 | 8,313 |
| 2023 | 3,367 | 2,047 | 2,133 | 18.65 | 495 | 2,450 | 10,028 |
| 2024 | 2,111 | 136 | 113 | 0.98 | 618 | 2,448 | 11,766 |
| 2025 | 2,172 | 276 | 226 | 2.11 | -408 | 2,400 | 12,444 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Pelagos Insurance Capital Limited bietet Versicherungs- und Rückversicherungslösungen in Bermuda, der Republik Irland und Großbritannien an. Es ist in zwei Segmenten tätig: Insurance und Reinsurance.
| Employees | 108 |
|---|---|
| Headquarters | Pembroke, Bermuda |
| Address | Wellesley House South, HM08 Pembroke, Bermuda |
| Phone | 441-279-2590 |
| Website | pelagosinsurancecapital.com |
| IPO Date | 29. Jun 2023 |
| ISIN | BMG3398L1182 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Daniel Burrows | Group CEO & Executive Director | 1969 |
| Allan Carl Decleir | Group CFO & Executive Director | 1965 |
| Jason Kittinger | Group Chief Operating Officer | 1980 |
| Miranda Hunter | Group Chief Investor Relations Officer | – |
| Nicole Kapu-Leyland | Group General Counsel | 1993 |
| Anneeka Patel | Group Chief Human Resources Officer | – |
| Ian Houston | Group & UK Chief Underwriting Officer | – |
| Michael Pearson | Group Chief Risk Officer | 1969 |
| Jonathan Strickle | Group Managing Director | 1988 |
| William Waddell-Dudley | Chief Underwriting Officer of UK | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.